Juan Wang

Dr. Juan Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Tissue Engineering Part A
Verified
Journal Article
Closed access
HWHuan Wu
Huan Wu
GYGuangfu Yin
Guangfu Yin
XPXiMing Pu
XiMing Pu
JWJuan Wang
Juan Wang
XLXiaoming Liao
Xiaoming Liao
ZHZhongbing Huang
Zhongbing Huang
BMP-2, VEGF and bFGF are important regulators of bone development and bone remodeling involving the coordination of osteoblast-mediated bone formation and osteoclast-mediated bone resorption. The synergistic promotions of these growth factors on osteogenesis in the appropriate combination have been confirmed by a lot of studies, but the effect of this combined application on osteoclastogenesis still remains some ambiguities. On the basis of comparing the osteoclastic potentials under stimulation of BMP-2, VEGF, or bFGF alone, this study focused on their combined effects on the differentiation and activity of osteoclasts. Our results showed that the osteoclastogenesis was enhanced in some extent under the stimulation of BMP-2, VEGF, or bFGF alone, and the potential of these three growth factors to stimulate osteoclastogenesis was VEGF > BMP-2 > bFGF. However, the treatment with the combination of BMP-2 (50 ng/ml), VEGF (1 ng/ml) and bFGF (10 ng/ml), the most suitable dose combination for osteogenesis optimized in our previous study, weakened osteoclast differentiation confirmed by smaller tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells, lower TRAP activity, and lower expression of dendritic cell-specific transmembrane protein (DC-STAMP), an important molecule regulating osteoclast fusion. Moreover, BMP-2, VEGF and bFGF in combination also moderately inhibited the bone-resorbing activity of mature osteoclasts by suppressing the expression of osteoclast-specific genes cathepsin K (CTSK) and matrix metalloproteinase-9 (MMP-9). The underlying molecular mechanisms involved the suppression of RANKL-induced c-Fos levels and the activation of NFATc1, two major transcription factors in osteoclast differentiation. Taken together, our study showed that the combination of BMP-2 (50 ng/ml), VEGF (1 ng/ml) and bFGF (10 ng/ml) promoted osteoblastogenesis but inhibited osteoclastogenesis. Thus, the simultaneous use of BMP-2 (50 ng/ml), VEGF (1 ng/ml) and bFGF (10 ng/ml) in an appropriate combination might improve efficacious bone regeneration in a clinical setting.